Abstract
Bergenin is the main chemical constituent of plants in the genus Bergenia, which are used in traditional medicines. Methylglyoxal (MG), a highly reactive dicarbonyl compound, is the major precursor for forming advanced glycation end products (AGEs). Pretreating MC3T3‐E1 cells with bergenin prevented MG‐induced protein adduct formation. Bergenin inhibited the MG‐induced soluble receptor for AGE (sRAGE), interleukin, reactive oxygen species and mitochondrial superoxide production. Additionally bergenin increased glyoxalase I activity, glutathione, heme oxygenase‐1 and nuclear factor erythroid 2‐related factor 2 levels in the presence of MG. Pretreatment with bergenin before MG exposure reduced MG‐induced mitochondrial dysfunction by preventing mitochondrial membrane potential dissipation, loss of adenosine triphosphate and reduced adenosine monophosphate‐activated protein kinase. These results demonstrate that bergenin may prevent the development of diabetic osteopathy.
Funding Information
  • Ministry of Education (NRF‐2016R1D1A1B03930082)

This publication has 60 references indexed in Scilit: